Paula Cipollone - Mar 8, 2024 Form 4 Insider Report for LifeStance Health Group, Inc. (LFST)

Role
Business Transformation Officer
Signature
By: /s/ Ryan Pardo, Attorney-in-Fact
Stock symbol
LFST
Transactions as of
Mar 8, 2024
Transactions value $
-$96,992
Form type
4
Date filed
3/12/2024, 09:50 PM
Previous filing
Apr 11, 2024
Next filing
May 14, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFST Common Stock Award $0 +62.4K +29.29% $0.00 276K Mar 8, 2024 Direct F1
transaction LFST Common Stock Award $0 +32.1K +11.63% $0.00 308K Mar 8, 2024 Direct F2
transaction LFST Common Stock Sale -$97K -14K -4.55% $6.93 294K Mar 11, 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 62,413 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 Represents performance-based restricted stock units previously granted to the Reporting Person, which vested on March 8, 2024.
F3 Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Remarks:

Business Transformation Officer